68Ga-bombesin

Also Known As:

68Ga-BBN

Networked: 3 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Peptide Hormones: 1347
    - Bombesin: 1127
      - 68Ga-bombesin: 3
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Nerve Tissue Proteins: 2
    - Neuropeptides: 6772
      - Bombesin: 1127
        68Ga-bombesin: 3
- Peptides: 82426
  - Neuropeptides: 6772
    - Bombesin: 1127
      - 68Ga-bombesin: 3
  - Peptide Hormones: 1347
    - Bombesin: 1127
      - 68Ga-bombesin: 3
Complex Mixtures: 1906
- Venoms: 4328
  - Amphibian Venoms: 77
    - Bombesin: 1127
      - 68Ga-bombesin: 3
Biological Factors: 2472
- Biological Toxins: 20
  - Venoms: 4328
    - Amphibian Venoms: 77
      - Bombesin: 1127
        68Ga-bombesin: 3
Inorganic Chemicals: 9

Experts

1.	Chen, Libo: 2 articles (01/2018 - 01/2017)
2.	Chen, Xiaoyuan: 2 articles (01/2018 - 01/2017)
3.	Fan, Xinrong: 2 articles (01/2018 - 01/2017)
4.	Lang, Lixin: 2 articles (01/2018 - 01/2017)
5.	Li, Fang: 2 articles (01/2018 - 01/2017)
6.	Niu, Gang: 2 articles (01/2018 - 01/2017)
7.	Zhang, Jingjing: 2 articles (01/2018 - 01/2017)
8.	Zhu, Zhaohui: 2 articles (01/2018 - 01/2017)
9.	Hou, Guozhu: 1 article (01/2018)
10.	Wu, Huanwen: 1 article (01/2018)

Related Diseases

1.	Prostatic Neoplasms (Prostate Cancer) 01/01/2017 - "We evaluated the safety and assessed the clinical diagnostic value of 68Ga-BBN-RGD PET/CT in prostate cancer patients in comparison with 68Ga-BBN. " 01/01/2018 - "This study was designed to analyze the safety, biodistribution, and radiation dosimetry of a gastrin-releasing peptide receptor (GRPR) antagonist PET tracer, 68Ga-RM26; to assess its clinical diagnostic value in prostate cancer patients; and to perform a direct comparison between GRPR antagonist 68Ga-RM26 and agonist 68Ga-BBN. "
2.	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/01/2007 - "Dynamic PET studies with a 68Ga-bombesin analog, DOTA-PEG2-[d-Tyr6, beta-Ala11,Thi13,Nle14] BN(6-14) amide (68Ga-BZH3; DOTA is 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid, and PEG is ethylene glycol [2-aminoethyl-carboxymethyl ether]), were performed on patients with gastrointestinal stromal tumors (GIST) to investigate the impact of complementary receptor scintigraphy on diagnosis and the potential of a radionuclide treatment. "
3.	Neoplasms (Cancer) 01/01/2017 - "Only 2 of 4 primary tumors, 5 lymph nodes, and 12 bone lesions were positive on 68Ga-BBN PET/CT, with the SUVmax of 2.98 ± 1.24, 4.17 ± 1.89, and 3.61 ± 1.85, respectively. "
4.	Lymphatic Metastasis 01/01/2018 - "Compared with 68Ga-RM26 PET/CT, GRPR agonist 68Ga-BBN PET/CT detected fewer primary lesions and lymph node metastases as well as demonstrated lower tracer accumulation. "
5.	Body Weight (Weight, Body) 01/01/2017 - "All the patients underwent PET/CT scans 15-30 min after intravenous injection of 1.85 MBq (0.05 mCi) per kilogram of body weight of 68Ga-BBN-RGD and also accepted 68Ga-BBN PET/CT within 2 wk for comparison. "

Related Drugs and Biologics

1.	Ethylene Glycol (Monoethylene Glycol)
2.	Bombesin Receptors (Bombesin Receptor)
3.	Radioisotopes (Radionuclides)
4.	Ether (Diethyl Ether)
5.	Amides
6.	Acids
7.	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

Related Therapies and Procedures

1.	Intravenous Injections